BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 8103937)

  • 1. Structure and function of phosphatidylinositol 3-kinase: a potential second messenger system involved in growth control.
    Fry MJ; Waterfield MD
    Philos Trans R Soc Lond B Biol Sci; 1993 Jun; 340(1293):337-44. PubMed ID: 8103937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solution structure of the C-terminal SH2 domain of the p85 alpha regulatory subunit of phosphoinositide 3-kinase.
    Siegal G; Davis B; Kristensen SM; Sankar A; Linacre J; Stein RC; Panayotou G; Waterfield MD; Driscoll PC
    J Mol Biol; 1998 Feb; 276(2):461-78. PubMed ID: 9512716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of an SH2 domain of the p85 alpha subunit of phosphatidylinositol-3-OH kinase.
    Booker GW; Breeze AL; Downing AK; Panayotou G; Gout I; Waterfield MD; Campbell ID
    Nature; 1992 Aug; 358(6388):684-7. PubMed ID: 1323062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two phosphorylation-independent sites on the p85 SH2 domains bind A-Raf kinase.
    Fang Y; Johnson LM; Mahon ES; Anderson DH
    Biochem Biophys Res Commun; 2002 Feb; 290(4):1267-74. PubMed ID: 11812000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative modes of binding of proteins with tandem SH2 domains.
    O'Brien R; Rugman P; Renzoni D; Layton M; Handa R; Hilyard K; Waterfield MD; Driscoll PC; Ladbury JE
    Protein Sci; 2000 Mar; 9(3):570-9. PubMed ID: 10752619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Backbone dynamics of the C-terminal SH2 domain of the p85alpha subunit of phosphoinositide 3-kinase: effect of phosphotyrosine-peptide binding and characterization of slow conformational exchange processes.
    Kristensen SM; Siegal G; Sankar A; Driscoll PC
    J Mol Biol; 2000 Jun; 299(3):771-88. PubMed ID: 10835283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formation of distinct signalling complexes involving phosphatidylinositol 3-kinase activity with stimulation of epidermal growth factor or insulin-like growth factor-I in human skin fibroblasts.
    Takahashi Y; Akanuma Y; Yazaki Y; Kadowaki T
    J Cell Physiol; 1999 Jan; 178(1):69-75. PubMed ID: 9886492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of the insulin receptor beta-subunit with phosphatidylinositol 3-kinase in bovine ROS.
    Rajala RV; Anderson RE
    Invest Ophthalmol Vis Sci; 2001 Dec; 42(13):3110-7. PubMed ID: 11726610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shb is a ubiquitously expressed Src homology 2 protein.
    Welsh M; Mares J; Karlsson T; Lavergne C; Bréant B; Claesson-Welsh L
    Oncogene; 1994 Jan; 9(1):19-27. PubMed ID: 8302579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A; Arai K
    Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specificity determinants of a novel Nck interaction with the juxtamembrane domain of the epidermal growth factor receptor.
    Hake MJ; Choowongkomon K; Kostenko O; Carlin CR; Sönnichsen FD
    Biochemistry; 2008 Mar; 47(10):3096-108. PubMed ID: 18269246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The three-dimensional solution structure of the SH2 domain from p55blk kinase.
    Metzler WJ; Leiting B; Pryor K; Mueller L; Farmer BT
    Biochemistry; 1996 May; 35(20):6201-11. PubMed ID: 8639560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A biosensor approach to probe the structure and function of the p85 alpha subunit of the phosphatidylinositol 3-kinase complex.
    End P; Gout I; Fry MJ; Panayotou G; Dhand R; Yonezawa K; Kasuga M; Waterfield MD
    J Biol Chem; 1993 May; 268(14):10066-75. PubMed ID: 7683666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of class IA PI3Ks: is there a role for monomeric PI3K subunits?
    Geering B; Cutillas PR; Vanhaesebroeck B
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):199-203. PubMed ID: 17371237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphatidylinositol 3-kinase: structure and expression of the 110 kd catalytic subunit.
    Hiles ID; Otsu M; Volinia S; Fry MJ; Gout I; Dhand R; Panayotou G; Ruiz-Larrea F; Thompson A; Totty NF
    Cell; 1992 Aug; 70(3):419-29. PubMed ID: 1322797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A region of the 85-kilodalton (kDa) subunit of phosphatidylinositol 3-kinase binds the 110-kDa catalytic subunit in vivo.
    Klippel A; Escobedo JA; Hu Q; Williams LT
    Mol Cell Biol; 1993 Sep; 13(9):5560-6. PubMed ID: 8395006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic activation of a family of phosphoinositide 3-kinase via G-protein coupled and tyrosine kinase-related receptors.
    Katada T; Kurosu H; Okada T; Suzuki T; Tsujimoto N; Takasuga S; Kontani K; Hazeki O; Ui M
    Chem Phys Lipids; 1999 Apr; 98(1-2):79-86. PubMed ID: 10358930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of phosphorylated insulin-like growth factor-I receptor with the SH2 domains of phosphatidylinositol 3-kinase p85.
    Yamamoto K; Altschuler D; Wood E; Horlick K; Jacobs S; Lapetina EG
    J Biol Chem; 1992 Jun; 267(16):11337-43. PubMed ID: 1317864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and characterization of the p85 subunit of the phosphatidylinositol 3-kinase complex and a related p85 beta protein by using the baculovirus expression system.
    Gout I; Dhand R; Panayotou G; Fry MJ; Hiles I; Otsu M; Waterfield MD
    Biochem J; 1992 Dec; 288 ( Pt 2)(Pt 2):395-405. PubMed ID: 1334406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin receptor substrate 1 binds two novel splice variants of the regulatory subunit of phosphatidylinositol 3-kinase in muscle and brain.
    Antonetti DA; Algenstaedt P; Kahn CR
    Mol Cell Biol; 1996 May; 16(5):2195-203. PubMed ID: 8628286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.